The use of individualized tumor response testing in treatment selection: second randomization results from the LRF CLL4 trial and the predictive value of the test at trial entry.

ABSTRACT:

SUBMITTER: Matutes E 

PROVIDER: S-EPMC3567236 | biostudies-literature | 2013 Feb

REPOSITORIES: biostudies-literature